Comparison of the clinical effects of combined salmeterol/fluticasone delivered by dry powder or pressurized metered dose inhaler

Pulmonary Pharmacology & Therapeutics
Masayuki HojoHaruhito Sugiyama

Abstract

The salmeterol/fluticasone combination (SFC) inhaler is currently the most widely used maintenance drug for asthmatics worldwide. Although the effectiveness of SFC as either a dry powder inhaler (DPI) or a pressurized metered dose inhaler (pMDI) is well documented, there is limited data comparing the clinical efficacies of the two devices. To address this issue, we carried out a randomized crossover trial in which asthmatic patients (n = 47; mean age, 62.5 ± 16.5 years old) received a 12-week treatment of SFC DPI (50/250 μg twice daily) or SFC pMDI (four puffs of 25/125 μg daily). After a 4-week washout period, patients received another crossover treatment for 12 weeks. Respiratory resistance and reactance were measured by forced oscillation technique (MostGraph-01), spirometry, fractional exhaled nitric oxide (FeNO), and an asthma control test (ACT) every 4 weeks. The mean forced expiratory volume1.0 at the baseline was 2.16 ± 0.86 (L). Respiratory system resistance at 5 Hz (R5), the difference between R5 and R at 20 Hz (R5 - R20), and FeNO improved in both treatment groups, while reactance at 5 Hz (X5) and ACT score improved only in the pMDI group. In patients >70 years old (n = 21), R5, R5 - R20, ΔX5, and FeNO improved only ...Continue Reading

References

Feb 28, 2002·The European Respiratory Journal·V Giraud, N Roche
Dec 19, 2003·The European Respiratory Journal·E OostveenUNKNOWN ERS Task Force on Respiratory Impedance Measurements
Oct 16, 2007·The Journal of Allergy and Clinical Immunology·L Keoki WilliamsManel Pladevall
Sep 26, 2008·Respiratory Medicine·John HaughneyLeif Bjermer
Jun 11, 2009·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Henry Chrystyn, David Price
Aug 1, 2009·American Journal of Respiratory and Critical Care Medicine·Jacqueline GambleLiam G Heaney
Jan 18, 2011·European Journal of Clinical Pharmacology·Arun NairBrian J Lipworth
May 27, 2011·Respiratory Medicine·David PriceJulie von Ziegenweidt
Dec 23, 2011·Allergology International : Official Journal of the Japanese Society of Allergology·Gen TamuraSatoshi Fujino
May 17, 2012·International Journal of Chronic Obstructive Pulmonary Disease·Yasuhiro YamauchiTakahide Nagase
Nov 3, 2012·Respiratory Physiology & Neurobiology·Kazutaka MoriKingo Chida
Jan 30, 2013·Respirology : Official Journal of the Asian Pacific Society of Respirology·Mitesh PatelRichard Beasley
Feb 6, 2013·The Journal of Allergy and Clinical Immunology·Erica van der WielMaarten van den Berge
Apr 23, 2013·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T ShiraiK Chida
Sep 5, 2013·Allergy, Asthma & Immunology Research·Toshihiro ShiraiKingo Chida
Jun 6, 2014·The Lancet. Respiratory Medicine·Brian LipworthWilliam Anderson
Jul 1, 2015·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Toshihiro ShiraiTakafumi Suda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.